Stamford, CT -- (SBWIRE) -- 12/16/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Federal Home Loan Mortgage Corp (OTCBB:FMCC), Globalstar, Inc. (OTCMKTS:GSAT), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT)
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) opened the session at $2.74, trading in a range of $2.74 - $2.92. The stock showed a positive performance of +1.09% in the last trading session from its previous close of $2.75 and closed at $2.78. The stock traded on a volume of 29.74 million shares and the average volume of the stock remained 28.29 million shares. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS). It operates in three segments: Single-Family Credit Guaranty, Multifamily, and Capital Markets. The Single-Family Credit Guaranty segment securitizes single-family mortgage loans into Fannie Mae MBS and facilitates the purchase of single-family mortgage loans for the company?s mortgage portfolio.
For How Long FNMA will Fight for Profitability? Read This Trend Analysis report
Federal Home Loan Mortgage Corp (OTCBB:FMCC) traded 17.68 million shares in the last business day while the average volume of the stock remained 12.64 million shares. The stock showed a positive movement of +1.95% to end at $2.61. The 52 week range of the stock remained $2.57 - $2.69. Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States. It operates in three segments: Single-Family Guarantee, Investments, and Multifamily. The Single-Family Guarantee segment purchases single-family mortgage loans originated by its seller/servicers in the primary mortgage market; securitizes the purchased mortgage loans into guaranteed mortgage-related securities; and guarantees the payment of principal and interest on the mortgage-related securities.
For How Long FMCC’s Gloss will Attract Investors? Find out via this report
Globalstar, Inc. (OTCMKTS:GSAT) reported 6.77 million shares were exchanged during the last trade, while the average volume is about 4.38 million shares. The stock dropped -1.01% and finished the day at $1.97. The beta of the stock is recorded at 3.08. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications; fixed voice and data satellite communications services in rural villages, ships, industrial and commercial sites, and residential sites; and satellite data modem services comprising asynchronous and packet data services. Its two-way transmission products also include Qualcomm GSP-1720 satellite voice and data modem.
Why Should Investors Buy GSAT After the Recent Fall? Just Go Here and Find Out
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) shares rose, +19.38 percent from its previous close of $1.29 to close at $1.54. Traded with volume of 4.47 million shares in the prior session and the average volume of the stock remained 614,140 shares. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis; and PH-10, a Phase IIc randomized study initiated drug candidate for the treatment of psoriasis.
Why Should Investors Buy PVCT After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)